CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.

@article{Kanner2010CD10PA,
  title={CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.},
  author={William A. Kanner and Louis B. Brill and James W. Patterson and Mark R. Wick},
  journal={Journal of cutaneous pathology},
  year={2010},
  volume={37 7},
  pages={744-50}
}
BACKGROUND Atypical fibroxanthoma (AFX) is a pleomorphic spindle cell lesion of the skin; it is considered in the differential diagnosis with spindle cell malignant melanoma (MM) and sarcomatoid carcinoma/spindle cell squamous cell carcinoma (SCC). An optimum approach has yet to fully emerge with respect to the immunohistochemical discrimination of these lesions. METHODS Departmental archives from 1978 onwards were searched for clinicopathologically confirmed cases of AFX, MM and SCC… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

Similar Papers

Loading similar papers…